Pet Pharm Biotech Co., Ltd. (TPEX:7762)
41.25
-5.40 (-11.58%)
At close: Nov 20, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.4 billion as of November 20, 2026. It is the 26,817th most valuable company in the world and the 1,413th biggest in Taiwan. Its market cap has decreased by 33.43% in one year.
Market Cap
2.40B
Enterprise Value
2.31B
Revenue
266.86M
Global Rank
Country Rank
#1,413 Taiwan
PE Ratio
51.10
ChartMarket Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.40B, an increase of 72.12%. That is a compound annual growth rate of 26.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.40B | -33.15% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 15.12B |
| Elixiron Immunotherapeutics (Cayman) Limited | 13.63B |
| Obigen Pharma | 7.29B |
| Intelligene | 7.08B |
| Uwell Biopharma | 5.13B |
| Tripartite Therapeutics | 3.31B |
| BIONET Therapeutics | 2.25B |
| Genomics BioSci & Tech. | 936.00M |